Although the FDA removed an amputation warning on Invokana’s box in 2020, the drug is still subject to active litigation.
Although the amputation risk while taking the diabetes drug is lower than scientists initially thought, Invokana can still pose serious risks of developing Fournier’s Gangrene.
Between 2013 and 2019, 21 cases of FG were reported among Invokana users. However, hundreds of Invokana-related lawsuits are pending in courts across the country.
Source: Consumer Safety